Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study.
Royer B, Kalbacher E, Onteniente S, Jullien V, Montange D, Piedoux S, Thiery-Vuillemin A, Delroeux D, Pili-Floury S, Guardiola E, Combe M, Muret P, Nerich V, Heyd B, Chauffert B, Kantelip JP, Pivot X. Royer B, et al. Br J Cancer. 2012 Jan 31;106(3):460-7. doi: 10.1038/bjc.2011.557. Epub 2011 Dec 15. Br J Cancer. 2012. PMID: 22173671 Free PMC article.
Circulating Biomarkers in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Treated With Everolimus in the Pre-nephrectomy Setting.
Mauge L, Phan L, Benhamouda N, Galy-Fauroux I, Badoual C, Topart D, Thiery-Vuillemin A, Le Moulec S, Guillot A, Cessot A, Mejean A, Albiges L, Tartour E, Fournier L, Helley D, Oudard S. Mauge L, et al. Clin Oncol (R Coll Radiol). 2023 Mar;35(3):e245-e255. doi: 10.1016/j.clon.2022.11.012. Epub 2022 Dec 14. Clin Oncol (R Coll Radiol). 2023. PMID: 36526521
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial.
Oudard S, Ratta R, Voog E, Barthelemy P, Thiery-Vuillemin A, Bennamoun M, Hasbini A, Aldabbagh K, Saldana C, Sevin E, Amela E, Von Amsberg G, Houede N, Besson D, Feyerabend S, Boegemann M, Pfister D, Schostak M, Huillard O, Di Fiore F, Quivy A, Lange C, Phan L, Belhouari H, Tran Y, Kotti S, Helissey C. Oudard S, et al. JAMA Oncol. 2023 Dec 1;9(12):1629-1638. doi: 10.1001/jamaoncol.2023.4255. JAMA Oncol. 2023. PMID: 37883073 Free PMC article.
Cost-effectiveness of avelumab first-line maintenance therapy for adult patients with locally advanced or metastatic urothelial carcinoma in France.
Porte F, Granghaud A, Chang J, Kearney M, Morel A, Plessala I, Cawston H, Roiz J, Xiao Y, Solbes MN, Lambert P, Ravaud A, Loriot Y, Thiery-Vuillemin A, Lévy P. Porte F, et al. Among authors: thiery vuillemin a. PLoS One. 2024 May 10;19(5):e0302548. doi: 10.1371/journal.pone.0302548. eCollection 2024. PLoS One. 2024. PMID: 38728337 Free PMC article.
[Induction chemotherapy in patients with head and neck cancer].
Chaigneau L, Guardiola E, N'Guyen T, Dufresne A, Stein U, Villanueva C, Thiery-Vuillemin A, Lorchel F, Pivot X. Chaigneau L, et al. Bull Cancer. 2006 Jul;93(7):677-82. Bull Cancer. 2006. PMID: 16873076 Free article. Review. French.
Anticancer therapy in patients with porphyrias: evidence today.
Thiery-Vuillemin A, Chaigneau L, Meaux-Ruault N, Villanueva C, N'guyen T, Maurina T, Stein U, Lorgis V, Demarchi M, Pivot X. Thiery-Vuillemin A, et al. Expert Opin Drug Saf. 2008 Mar;7(2):159-65. doi: 10.1517/14740338.7.2.159. Expert Opin Drug Saf. 2008. PMID: 18324878
Safety profile of new anticancer drugs.
Mansi L, Thiery-Vuillemin A, Nguyen T, Bazan F, Calcagno F, Rocquain J, Demarchi M, Villanueva C, Maurina T, Pivot X. Mansi L, et al. Expert Opin Drug Saf. 2010 Mar;9(2):301-17. doi: 10.1517/14740330903530663. Expert Opin Drug Saf. 2010. PMID: 20175699 Review.
134 results